Kidney Technology Development Research Education Program (R25 - Independent Clinical Trial Not Allowed)
ID: 353368Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $130K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
  1. 1
    Forecast Posted Not available
  2. 2
    Forecast Due Not available
  3. 3
    Posted Apr 3, 2024 12:00 AM
  4. 4
    Due Jun 15, 2025 12:00 AM
Description

The National Institutes of Health (NIH) is offering a grant opportunity titled "Kidney Technology Development Research Education Program" under the category of Health. This grant aims to support institutions in establishing research experiences in kidney technology development. The program seeks to recruit undergraduate students, particularly those from engineering and technical domains, to participate in collaborative capstone research or design projects. The grant also encourages the inclusion of medical students, graduate students, and dual-degree students prior to their qualifying exams and selection of a Ph.D. mentor. Successful programs should focus on innovative and ground-breaking technology development, multidisciplinary teamwork, education in entrepreneurship, product development, navigating regulatory pathways, and clinical immersion. The grant does not require cost sharing or matching funds. The maximum award ceiling for this grant is $130,000. The closing date for applications is June 15, 2025. For more information and to apply, visit the following link: Kidney Technology Development Research Education Program. For any inquiries, contact NIH Grants Information at grantsinfo@nih.gov.

Point(s) of Contact
Files
Title
Posted
4/20/2024
Similar Opportunities
Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed)
Active
National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "Catalytic Tool and Technology Development in Kidney, Urologic, and Hematologic Diseases (R21 Clinical Trial Not Allowed)". This grant aims to promote the development of innovative tools and technologies in the areas of kidney, urologic, and hematologic diseases. The grant does not require cost sharing or matching. The funding instrument type is a grant, and the category of funding activity is health. The grant is open to various eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions, Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities, Indian/Native American Tribal Governments, Non-domestic Entities, Regional Organizations, Tribally Controlled Colleges and Universities, and U.S. Territories or Possessions. The grant has a closing date of January 7, 2025, and an award ceiling of $275,000. For more information and to apply, visit the following link: [http://grants.nih.gov/grants/guide/pa-files/PAR-23-119.html](http://grants.nih.gov/grants/guide/pa-files/PAR-23-119.html). For any inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
NIDDK Education Program Grants (R25 Clinical Trial Not Allowed)
Active
National Institutes of Health
The National Institutes of Health (NIH) is offering NIDDK Education Program Grants through a Grant opportunity titled "NIDDK Education Program Grants (R25 Clinical Trial Not Allowed)". This grant opportunity falls under the category of Health and is posted on grants.gov. The purpose of this grant is to support educational activities that complement and enhance the training of a workforce to meet the nation's biomedical, behavioral, and clinical research needs. The NIDDK Education Program Grants will primarily focus on two areas: courses for skills development and research experiences. These educational activities must align with NIDDK's mission areas, which include diabetes and other endocrine and metabolic diseases, digestive diseases, nutritional disorders, obesity, and kidney, urologic, and hematologic diseases. The grant does not require cost sharing or matching requirements. The funding instrument type is a Grant, and the opportunity category is Discretionary. The CFDA number associated with this grant is 93.847. Eligible applicants for this grant include Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), eligible agencies of the Federal Government, faith-based or community-based organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), regional organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. Territory or Possession. Non-domestic (non-U.S.) entities and non-domestic components of U.S. organizations are not eligible to apply. The closing date for this grant opportunity is January 30, 2026. The award ceiling is $100,000. The grant description and additional information can be found on the NIH website at [http://grants.nih.gov/grants/guide/pa-files/PAR-24-074.html](http://grants.nih.gov/grants/guide/pa-files/PAR-24-074.html). For any inquiries or further information, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.
Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed)
Active
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C - Clinical Trial Not Allowed)". This grant aims to cultivate a highly integrated cohort of trainees and early career investigators and develop career development resources to accelerate kidney, urologic, and hematologic research. The grant encourages institutions to submit a single, unified U2C-TL1 application to engage, recruit, prepare, and sustain the next generation of scientists in advancing research in kidney, urology, and hematology. Applications representing multiple institutions within a single metropolitan area are strongly encouraged. The grant does not require cost sharing or matching. The funding instrument type is a cooperative agreement. The category of funding activity is health. The grant is open to eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), eligible agencies of the federal government, faith-based or community-based organizations, Hispanic-serving institutions, historically Black colleges and universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), regional organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. territories or possessions. Non-domestic (non-U.S.) entities (foreign organizations) and non-domestic (non-U.S.) components of U.S. organizations are not eligible to apply. The close date for this grant opportunity is September 26, 2025. For more information and to apply, visit the following link: [http://grants.nih.gov/grants/guide/pa-files/PAR-23-248.html](http://grants.nih.gov/grants/guide/pa-files/PAR-23-248.html). For any inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
Focused Technology Research and Development (R01 Clinical Trial Not Allowed)
Active
National Institutes of Health
The National Institutes of Health (NIH) is offering a grant opportunity titled "Focused Technology Research and Development (R01 Clinical Trial Not Allowed)". This grant falls under the category of Health and is a discretionary funding opportunity. The grant does not require cost sharing or matching. The purpose of this grant is to support projects that focus solely on the development of technologies with the potential to enable the acquisition of basic biomedical knowledge. The projects should be justified in terms of technical innovation and utility for future biomedical impact. The expected outcome of this research is functioning prototype instruments, methods, synthetic approaches, biological products, etc., that are characterized adequately to be ready for first application to the type of biomedical research questions that provide the rationale for their development. It is important to note that the application of the proposed technology to specific biomedical questions is considered beyond the scope of the program and should not be included in the proposal. Proof of principle for the technology should have already been shown, but there will still be significant fundamental technical challenges. Therefore, applications should include preliminary data. Projects that have significant remaining risk but are supported by early feasibility studies might be appropriate for a three-year R01 proposal with a reduced budget to better manage risk and investment. On the other hand, projects that are well supported by feasibility studies and propose to develop fully functional prototypes might require higher budgets and a four-year duration (five years for early stage investigators). Projects that primarily focus on optimization, hardening, or obvious extrapolations of established technology might be less competitive. The eligibility for this grant is open to various types of applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. Territory or Possession. However, Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply, and non-domestic components of U.S. Organizations are also not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. The closing date for this grant opportunity is May 7, 2025. For more information and to apply, please visit the following link: [http://grants.nih.gov/grants/guide/pa-files/PAR-22-127.html](http://grants.nih.gov/grants/guide/pa-files/PAR-22-127.html). If you have any inquiries, you can contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
NICHD Research Education Programs (R25 Clinical Trial Not Allowed)
Active
National Institutes of Health
The National Institutes of Health (NIH) is offering a grant opportunity titled "NICHD Research Education Programs (R25 Clinical Trial Not Allowed)" under the category of Income Security and Social Services. This grant aims to support creative educational activities that primarily focus on research skills development. The grant does not cover mentoring activities or professional skills development, but it does allow for informal mentoring activities and professional skills development associated with courses for research skills development. The grant does not require cost sharing or matching. The maximum award ceiling for this grant is $150,000. The eligible applicants include various institutions and organizations such as Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and Historically Black Colleges and Universities (HBCUs), among others. Non-domestic (non-U.S.) entities and components are not eligible to apply, except for foreign components as defined in the NIH Grants Policy Statement. The closing date for this grant opportunity is May 25, 2025. For more information and to apply, please visit the following link: [NICHD Research Education Programs Grant](http://grants.nih.gov/grants/guide/pa-files/PAR-22-224.html). For any inquiries, please contact NIH Grants Information at grantsinfo@nih.gov.